Instem Taps ex-Novartis Head of Emerging Technologies to Put Science Behind Practical AI and NAMs [Yahoo! Finance]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance
In the role, Szczepan will lead scientific and AI strategy across in silico predictive modeling, translational safety analytics, and data-driven drug development solutions. Building the Regulatory Infrastructure From the Inside Out Szczepan spent the last decade building the regulatory infrastructure for AI-driven preclinical science, not from inside it, but at the table where the rules get made. At Novartis, he led Emerging Technologies. At VeriSIM Life, he served as Chief Scientific Officer. Currently, he co-chairs the FNIH Validation & Qualification Network (VQN), representing industry, the body setting evidentiary standards for New Approach Methodologies (NAMs) acceptance across the U.S. FDA and EMA. He co-founded and now co-chairs the 3Rs Collaborative's AI Initiative alongside the U.S. FDA, placing him at the intersection of AI, translational science, and the emerging evidence expectations shaping preclinical development. At Instem, Szczepan's role is to deepen the scienti
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Nomination Committee's proposal to the Board of Directors for IRLAB Therapeutics' Annual General Meeting 2026 [Yahoo! Finance]Yahoo! Finance
- Missing general, scientist deaths tied to secret US work prompt White House probe [FOX News]FOX News
- Exclusive: Carrie Ann Inaba reveals in-flight emergency, gives update [USA TODAY]USA TODAY
- Middle East and North Africa (MENA) Medical Device Regulatory Requirements and Developments Course: Navigate Product Approvals and Capitalize on the Region's Growing Demand (May 18th - May 19th, 2026) [Yahoo! Finance]Yahoo! Finance
- Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030GlobeNewswire
NVS
Earnings
- 2/4/26 - Beat
NVS
Sec Filings
- 3/18/26 - Form 6-K
- 3/17/26 - Form FWP
- 2/12/26 - Form 144
- NVS's page on the SEC website